In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Rapidly-emerging variants jeopardize antibody-based countermeasures against SARS-CoV-2. While recent cell culture experiments have demonstrated loss of potency of several anti-spike neutralizing antibodies against SARS-CoV-2 variant strains1-3, the in vivo significance of these results remains uncer...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Michael, Chen, Rita, Winkler, Emma, Case, James, Aziati, Ishmael, Bricker, Traci, Joshi, Astha, Darling, Tamarand, Ying, Baoling, Errico, John, Shrihari, Swathi, VanBlargan, Laura, Xie, Xuping, Gilchuk, Pavlo, Zost, Seth, Droit, Lindsay, Liu, Zhuoming, Stumpf, Spencer, Wang, David, Handley, Scott, Stine, W, Shi, Pei-Yong, Garcia-Knight, Miguel, Andino, Raul, Chiu, Charles, Ellebedy, Ali, Fremont, Daved, Whelan, Sean, Crowe, James, Purcell, Lisa, Corti, Davide, Boon, Andrianus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132254/
https://www.ncbi.nlm.nih.gov/pubmed/34013259
http://dx.doi.org/10.21203/rs.3.rs-448370/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132254/
https://www.ncbi.nlm.nih.gov/pubmed/34013259
http://dx.doi.org/10.21203/rs.3.rs-448370/v1

Ejemplares similares